Skip to content
  • Sunday, 26 July 2026
  • 2:05 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets
Pharmaceutical R&D

Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets

Teuku Ryan Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has granted approval for a higher-dose formulation of Novo Nordisk’s blockbuster weight-loss medication,…

Read More
Pharmaceutical R&D

Expert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges

Teuku Ryan Mar 20, 2026 0

Despite promising clinical outcomes from the first-ever gene therapy trial for Huntington’s Disease (HD), a leading expert involved in the…

Read More
Pharmaceutical R&D

Meningitis B Vaccine Expansion Under Consideration Amidst Kent Outbreak

Teuku Ryan Mar 18, 2026 0

The United Kingdom’s Health Secretary, Wes Streeting, is reportedly considering expanding the national immunisation schedule to include the Meningitis B…

Read More
Neuroscience & Brain Research

Parkinson’s Disease Research Reaches Pivotal Point Amidst Funding and Trial Hurdles

rifanmuazin Mar 14, 2026 0

The scientific understanding of Parkinson’s disease (PD) has advanced significantly, placing preclinical and clinical research at a critical juncture. However,…

Read More

Posts pagination

1 … 5 6
Eli Lilly and Profluent Partner to Harness AI for Advanced Recombinase-Based Gene EditingTWiV 1284: Clinical Update with Dr. Daniel GriffinMIT Engineers Uncover Dual Mechanism of Exercise-Induced Nerve Growth Through Biochemical and Physical SignalingFirst Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ